Core Insights - Niagen Bioscience, Inc. (NASDAQ: NAGE) is recognized as a global authority on NAD+ with a focus on healthy aging science [1] - The company has expanded the availability of its pharmaceutical-grade Niagen Plus™ products, including Niagen IV and injections, to over 50 iCRYO locations across the U.S., increasing access to more than 900 clinics nationwide [1] Company Developments - The partnership with iCRYO enhances the distribution of Niagen Bioscience's innovative and science-backed NAD+ boosting products [1]